Clinical Trial Update: Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating crenolanib as maintenance therapy after allogeneic stem cell transplantation in FLT3-positive acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Crenolanib (Crenolanib)

Snippet

Sponsor: Arog Pharmaceuticals, Inc. | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2023-12-18